Triathlon Total Knee System - Triathlon X3 Medial Stabilized Tibial Bearing Insert
by Howmedica Osteonics Corp., Dba Stryker Orthopaedics
510(k) K253637
Active
Valid until
No expiry
FDA recalls
None foundDocuments
Trust
Unverified
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK253637 | Date18 Feb 2026 | StatusActive |
Recalls
No FDA recalls found in the data synced 22 Oct 2026.
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Specification
- 510(k) Number
- FDA Product Code
- MBH
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3565
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 20 Sep 2026
The Triathlon X3 Medial Stabilized Tibial Bearing Insert is a medial stabilized tibial bearing designed as a component of the Triathlon Total Knee System for total knee arthroplasty. It is classified as an orthopedic implant with an asymmetric articulating surface intended to enhance medial conformity with compatible femoral components. This insert is engineered to support primary or revision knee replacement procedures, improving joint stability and alignment. Its design emphasizes sagittal stability to optimize knee function post-implantation.
This device is supplied as a sterile, single-use implant and is intended for use in orthopedic surgical settings. It is part of the Triathlon Total Knee System, requiring compatible femoral components for proper function. The insert is regulated under FDA 510(k) clearance (K253637) and falls under the MBH product code for orthopedic knee prostheses. Storage and handling must adhere to sterile surgical protocols to maintain integrity before use.
Other devices from Howmedica Osteonics Corp., Dba Stryker Orthopaedics
See all devices from Howmedica Osteonics Corp., Dba Stryker Orthopaedics →
Questions
AI-generated answers, 20 Sep 2026
What types of knee replacement surgeries is the Triathlon X3 Medial Stabilized Tibial Bearing Insert designed for?
The Triathlon X3 Medial Stabilized Tibial Bearing Insert is specifically designed for use in both primary and revision total knee arthroplasty procedures. Its asymmetric articulating surface and medial stabilization are engineered to enhance joint stability and alignment, making it suitable for surgeries where improved knee function and sagittal stability are priorities.
Is this tibial bearing insert compatible with all femoral components, or does it require specific pairing?
This insert is part of the Triathlon Total Knee System and is intended for use only with compatible femoral components from the same system. The asymmetric design relies on matching geometry to ensure proper articulation and stability, so pairing with non-compatible femoral components could compromise performance.
How should the Triathlon X3 Medial Stabilized Tibial Bearing Insert be stored and handled before use?
As a sterile, single-use implant, the insert must be stored and handled according to standard sterile surgical protocols to preserve its integrity. This includes maintaining sealed packaging until immediate preoperative use and adhering to manufacturer guidelines for temperature and humidity control to prevent contamination or degradation.
What distinguishes the medial stabilization feature of this tibial bearing insert?
The medial stabilization feature of the Triathlon X3 insert is designed to improve conformity between the tibial plateau and femoral component on the medial side of the knee. This asymmetric articulating surface helps reduce stress concentrations and enhances stability during flexion and extension, particularly for patients requiring precise alignment in total knee replacements.
Is this device regulated under a specific FDA pathway, and what does that mean for its use?
The Triathlon X3 Medial Stabilized Tibial Bearing Insert is cleared under the FDA’s 510(k) pathway (K253637) with a determination of *Substantially Equivalent* to a predicate device. This means it has been evaluated by the FDA Orthopedic (OR) Advisory Committee and deemed comparable in safety and effectiveness to an existing orthopedic knee prosthesis, allowing for its use in clinical settings where total knee arthroplasty is performed.